ArticleAIDS (London, England)2017

Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?

Alana T Brennan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.